106 results
Page 3 of 6
6-K
EX-99.1
ovjlu mlq0xin
21 Dec 22
Current report (foreign)
6:01am
6-K
ebrtfnrtgx3qaa z1dfa
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
9kujb3pru3rly dqraq
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
251dp xtkshgs8e
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
h3ays9vzwbqevemyh
30 Nov 22
Current report (foreign)
6:28am
6-K
ddr ms9ahv9
14 Oct 22
Current report (foreign)
7:36am
6-K
zcq050ajimcybcuu
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
x3v92b 4v8j
23 Aug 22
Current report (foreign)
6:13am
6-K
f2fos 2xto3adwy8y
11 Jul 22
Current report (foreign)
6:05am
6-K
6io0xatme4eu8me
29 Jun 22
Current report (foreign)
6:02am
6-K
pjvnom2lagqkt
24 Jun 22
Current report (foreign)
6:08am
6-K
9ga69p1kp7
1 Jun 22
Current report (foreign)
6:08am
6-K
l4jvlfqy
31 May 22
Current report (foreign)
6:20am
6-K
EX-99.1
ugq99ao 2g
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
en9ar77op4qml
31 May 22
Current report (foreign)
6:07am
6-K
fs8vkkk zqs
11 May 22
Current report (foreign)
6:11am
6-K
vwzb yb8uxdh
11 May 22
Current report (foreign)
6:06am
6-K
7gwylm k1w53
19 Apr 22
Current report (foreign)
6:07am
6-K
1eo0sch4jk se
13 Apr 22
Current report (foreign)
6:41am